ArticleCancers2023

Indirect Treatment Comparison of First-Line CDK4/6-Inhibitors in Post-Menopausal Patients with HR+/HER2- Metastatic Breast Cancer.

Joseph J Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.